GeoVax Labs Statistics
NASDAQ: GOVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.281-0.0056 (-1.95%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GeoVax Labs by the numbers
GeoVax Labs has a market capitalization of $2.8 million based on 10.10M shares outstanding. With trailing EPS of $-8.84, GeoVax Labs is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 47.3% below its 50-day average and 82.3% below its 200-day average.
Average daily trading volume is 771.47K shares, or about $216,782 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GOVX valuation vs. peer median
| Metric | GOVX | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.84M | $2.91M | -3% |
| Avg. volume | 771.47K | 236.88K | +226% |
Peer median across 8 companies: MTNB, SILO, REVB, MBIO, KAPA, PRFX, SPRC, XRTX.
Valuation
- Market cap
- $2.84M
- EPS (TTM)
- $-8.84
- Shares outstanding
- 10.10M
Price and trading
- Previous close
- 0.2866
- Open
- 0.28
- Day range
- 0.2705 – 0.2929
- 52-week range
- 0.2705 – 15.75
- 50-day moving average
- 0.5329
- Beta
- —
- Volume
- 230.75K
- Average volume
- 771.47K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Mar 23, 2026
Additional statistics
- Market Cap
- 2.84M
- Forward Pe
- -0.33
- Eps
- -8.84
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.75
- Week52 Low
- 0.27
- Avg Volume
- 771.47K
- Shares Outstanding
- 10.10M
- Ma50
- 0.53
- Ma200
- 1.59
- Earnings Date
- Mar 23, 2026
- Pct From52w High
- -98.22%
- Pct From52w Low
- 3.88%